Abstract
Background: Robotic surgery has gain popularity in the past decades. We aim to investigate the impact of robotic surgery in gynecologic cancer. Methods: By retrospectively collecting demographics of those with gynecologic cancer performed by robotic surgery and addressing the perioperative and oncologic outcomes as the primary end points. Results: A total of 67 patients with 23 cervical cancer, 41 endometrial cancer. Amongst those with cervical cancer there were 15 (71.43%) international federation of gynecology and obstetrics (FIGO) stage 1 and 3 (14.29%) FIGO stage 2 with a median tumor size of 30.5 mm and a median 17 (0-42) lymph nodes retrieved with blood loss of 80 cc (5-500 cc). 6 recurrences (3 local/regional; 3 distant metastasis) with 5 succumb to disease with a 5-year disease-free and overall survival of 71.3%. In those with endometrial cancer there were 41 patients with 34 (85%) early stage (FIGO stage 1/2), 6 (15%) advanced stage (3/4). Median lymph nodes retrieval of 22 (0-60) and blood loss of 30 cc (1-2000 cc) were documented. There were 2 recurrences with 5 year disease-free and overall survival of 94.3% and 94.4% respectively. Conclusion: While robotic surgery has a superior surgical with comparable oncologic outcome in endometrial cancer, it should be used cautiously in unselected cervical cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
